Pricing Log in Create free account

Alps Group Inc. (ALPS) vs Connect Biopharma Holdings Limited Sponsored ADR (CNTB)

Alps Group Inc. and Connect Biopharma Holdings Limited Sponsored ADR are both Biotechnology companies. Alps Group Inc. and Connect Biopharma Holdings Limited Sponsored ADR are of similar size ($57.1M and $56.4M). Alps Group Inc. has the higher net margin (0.00% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Alps Group Inc. leads on 9 and Connect Biopharma Holdings Limited Sponsored ADR on 2.

Valuation

Metric ALPS CNTB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 19.07 9.71
P/B n/m 2.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 8.64 9.21
Earnings yield (222.97%) (130.77%) (33.15%)
Free cash flow yield (82.17%) (106.62%) (25.50%)

Profitability

Metric ALPS CNTB Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (2,346.35%) 0.00%
Net margin 0.00% (2,298.93%) 0.00%
Free cash flow margin 0.00% (2,018.76%) 0.00%
Return on equity 25.50% (140.51%) (56.36%)
Return on assets 0.00% (109.34%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALPS CNTB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 21.95% (257.14%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALPS CNTB Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 0.04 2.37 4.72
Net debt to EBITDA 0.00 0.77 0.96

Dividend

Metric ALPS CNTB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALPS CNTB Biotechnology median
Market cap 56.41m 57.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack